文献速递心境障碍儿童青少年精神

抑郁多基因风险与高危青少年终生抑郁的关联

Association between polygenic liability to depression and lifetime depression in at-risk adolescents.
PubMed 文献 · Mol Psychiatry · 2026-10-06

该研究基于澳大利亚布里斯班两个纵向人群队列的 mega 分析,纳入 302 例终生重性抑郁障碍(MDD)病例和 1693 名对照,评估 14 岁时内化症状与 MD-PGS 对青年期终生 MDD 的风险分层作用。结果显示,内化症状和 MD-PGS 各自最高十分位均与终生 MDD 风险升高相关,二者同时处于最高十分位者风险约升高八倍。

要点

  • 14 岁时内化症状最高十分位者终生 MDD 风险升高超过两倍(OR=2.56)。
  • MD-PGS 最高十分位者终生 MDD 风险升高约三倍余(OR=3.45)。
  • 内化症状与 MD-PGS 均处最高十分位者终生 MDD 风险约升高八倍(OR=8.58)。

核心结论

  • 抑郁多基因风险评分可能有助于对已有内化症状升高的青少年进行风险分层,识别日后 MDD 极高风险亚组。

研究设计与样本

  • 研究为两个澳大利亚布里斯班纵向人群队列的 mega 分析,纳入 302 例终生 MDD 病例和 1693 名对照。
  • 内化症状于 14 岁评估,终生 MDD 于青年期用复合国际诊断交谈(CIDI)评估,MD-PGS 基于排除澳大利亚队列的最新 PGC 重性抑郁 GWAS 汇总统计生成。

主要发现

  • 14 岁时内化症状最高十分位者终生 MDD 的 OR=2.56(95%CI 1.92-3.49,p=5.4×10^-10)。
  • 内化症状与 MD-PGS 同时处于最高十分位者终生 MDD 的 OR=8.58(95%CI 4.04-18.26,p=1.2×10^-5)。

关键数值与推荐

  • 分析以各队列风险最高十分位与其余 90% 进行比较。
  • MD-PGS 使用排除澳大利亚队列的 PGC 重性抑郁 GWAS 汇总统计生成。

临床怎么用

  • 对 14 岁已有内化症状升高的青少年,可结合 MD-PGS 进一步分层识别 MDD 极高风险者。
  • 内化症状与 MD-PGS 双重高危的青少年或需更密切监测与早期干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Internalising symptoms including depression, anxiety and somatic symptoms in adolescence are common. They can be transient, but they can also persist and progress to major depressive disorder (MDD) Polygenic risk scores for major depression (MD-PGS) may help identify which symptomatic adolescents are at greatest risk of later disorder. In a mega-analysis of two longitudinal population-based cohorts from Brisbane, Australia, we investigated whether polygenic liability to depression improves risk stratification among adolescents with elevated internalising symptoms. Internalising symptoms were assessed at age 14, lifetime MDD was assessed in young adulthood using the Composite International Diagnostic Interview, and MD-PGS were generated using summary statistics from the latest Psychiatric Genomics Consortium major depression genome-wide association study, excluding Australian cohorts. Analyses focused on comparisons between individuals in the top decile of risk and those in the remaining 90% of each cohort. A total of 302 cases with lifetime MDD and 1693 controls were included. Compared with adolescents outside the highest decile of internalising symptoms, those in the top decile at age 14 had a more than two-fold increased odds of lifetime MDD (OR = 2.56, 95% CI 1.92-3.49, p = 5.4 × 10-10). Individuals in the top decile of MD-PGS also showed increased odds of lifetime MDD compared with the remaining 90% (OR = 3.45, 95% CI 2.53-4.71, p = 4.4 × 10-¹⁵). Adolescents who were simultaneously in the top decile of both internalising symptoms and MD-PGS had an approximately eight-fold increased odds of lifetime MDD compared with individuals outside the top decile for both risk factors (OR = 8.58, 95% CI 4.04-18.26, p = 1.2 × 10-⁵). These findings indicate that polygenic risk scores for depression may have particular clinical utility for stratifying risk among adolescents already presenting with elevated internalising symptoms, identifying a subgroup at very high risk for later major depressive disorder.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Byrne EM, Gillespie NA, Najman JM, et al. Association between polygenic liability to depression and lifetime depression in at-risk adolescents. Mol Psychiatry. 2026. PMID: 42839001. doi:10.1038/s41380-026-03917-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。